|
2024
|
Invention
|
Controlled release pde10a formulations. NSSS)-2-(5-methylpyridin-2-yl)cyclopropyl)methoxy)pyrimid... |
|
2020
|
Invention
|
Process for the preparation of intermediates useful for making (2s,5r)-7-oxo-n-piperidin-4-yl-6-(... |
|
2018
|
Invention
|
Pegylated interleukin-10. Interleukin-10 (IL-10) conjugated via a linker to one or more polyethyl... |
|
2017
|
Invention
|
Methods for treatment of cancer with therapeutic combinations comprising peg-il-10. Provided are ... |
|
|
Invention
|
Methods of preparing hydroxylamine derivatives useful in the preparation of anti-infective agents... |
|
2016
|
Invention
|
Process for making m1 receptor positive allosteric modulators. This invention provides novel proc... |
|
|
Invention
|
4'-substituted nucleoside reverse transcriptase inhibitors and preparations thereof. The present ... |
|
2015
|
Invention
|
Substituted phosphoramidate compounds and uses thereof. The present invention is directed to Comp... |
|
|
Invention
|
Process for making tetracyclic heterocycle compounds.
The present invention is directed to a pro... |
|
|
Invention
|
Process for making tetracyclic heterocycle compounds. The present invention is directed to a proc... |
|
2014
|
Invention
|
Oral pharmaceutical formulation of omarigliptin. The present invention is directed to stable, ora... |
|
2012
|
Invention
|
Crystal forms of a hcv protease inhibitor. The present invention relates to different forms of a ... |
|
|
Invention
|
Methods and intermediates for preparing macrolactams. The present invention includes compounds us... |
|
|
Invention
|
Process for preparing chiral dipeptidyl peptidase-iv inhibitors. A process for the preparation of... |
|
|
Invention
|
Novel crystalline forms of a dipeptidyl peptidase-iv inhibitor. Novel crystalline forms of (2R,3S... |
|
|
Invention
|
Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with simvastatin... |
|
|
Invention
|
Process for the preparation of an orexin receptor antagonist. The present invention is directed t... |
|
2010
|
Invention
|
Formulations for c-met kinase inhibitors. The instant invention relates to pharmaceutical composi... |
|
|
Invention
|
Crystalline hydrochloride salts of c-met kinase inhibitors. The instant invention relates to crys... |
|
2009
|
Invention
|
Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia. The present invention... |
|
|
Invention
|
Use of nmda activity enhancers to treat hypersomnia, reduced wakefulness or reduced vigilance.
T... |
|
|
Invention
|
Use of nmda activity enhancers to treat hypersomnia, reduced wakefulness or reduced vigilance. Th... |
|
|
Invention
|
Substituted dihydroisoquinolinone and isoquinolinedione derivatives as calcium channel blockers. ... |
|
|
Invention
|
3, 4 - substituted piperidine derivatives as renin inhibitors. The present invention relates to 3... |
|
2008
|
Invention
|
Methods for predicting treatment response based on the expression profiles of biomarker genes in ... |
|
|
Invention
|
Use of erythropoietin to develop small molecule inhibitors of janus kinase-2.
The invention pert... |
|
|
Invention
|
Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disord... |
|
2007
|
Invention
|
Imidazothiazole derivatives as mark inhibitors.
Compounds of formula (I): are inhibitors of MARK... |
|
|
Invention
|
Aminothiazole derivatives as inhibitors of mark.
Compounds of formula (I): inhibit microtubule a... |
|
|
Invention
|
3-animopyraolines for treatment of neurodegenerative and psychiatric diseases.
Compounds of the ... |
|
|
Invention
|
Indazole derivatives for treatment of alzheimer's disease.
Compounds of formula (IA) and (IB) ar... |
|
|
Invention
|
Upregulation of adamts4 protease activity for the treatment of alzheimer's disease.
The inventio... |
|
|
Invention
|
Treatment of alzheimer's disease and related conditions.
Compounds of formula (I) inhibit microt... |
|
2006
|
Invention
|
Tetrahydroindole derivatives for treatment of alzheimer's disease. Tetrahydroindole derivatives o... |
|
|
Invention
|
Method for identifying modulators of gamma secretase or notch.
The present invention relates to ... |
|
|
Invention
|
Process for the preparation of bicyclo[3.1.0]hexanols. 3-7 cycloalkenyl ring.
|
|
|
Invention
|
Mutants of human app and their use for the production of transgenice animals.
A modified amyloid... |
|
|
Invention
|
Inhibitors of glyt1 transporters. 4, Ar, A, n and m are defined herein, is disclosed as a GlyT1 i... |
|
|
Invention
|
Sulphone derivatives for treatment of cancer.
Compounds of Formula (I) are disclosed for treatme... |
|
|
Invention
|
2,3-substituted fused bicyclic pyrimidin-4(3h)-ones which modulating the function of the vanilloi... |
|
|
Invention
|
Process for the preparation of tetrazolytetrahydrocyclopentapyrazoles. 2 are linked and, together... |
|
|
Invention
|
2,3-substituted fused pyrimidin -4 (3h)-ones as vr1 antagonists.
A compound of formula (I), wher... |
